Security · featured owners
RIGL Rigel Pharmaceuticals Inc.
Health Care COM Equity as of 2026 Q2 among managers we track
- 1 exit
holders
sorted by value · long equity only · current book 2026 Q2 · exits show last held size · open a manager for their book
| history | |||||
|---|---|---|---|---|---|
| James Silverman - Opaleye Management exited 2026 Q2 last 2026 Q1 | 0.25% | Exit −0.25% | 70,000 | $2M | history |
SEC filings
Recent issuer filings from EDGAR · 12 shown · open Filing / Doc on SEC.gov
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.01 | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| 8-K | 1.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.02 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Insider forms
Form 3 / 4 / 5 from EDGAR · 8 rows shown
| Filed | Form | Detail | Links |
|---|---|---|---|
| 4 | Period Sep 1, 2026 · 4 forms | Filing Doc | |
| 4 | Period Jul 8, 2026 | Filing Doc | |
| 4 | Period Jun 22, 2026 | Filing Doc | |
| 4 | Period Jun 17, 2026 · 5 forms | Filing Doc | |
| 4 | Period Jun 1, 2026 · 5 forms | Filing Doc | |
| 4 | Period May 26, 2026 | Filing Doc | |
| 4 | Period May 15, 2026 · 7 forms | Filing Doc | |
| 4 | Period Feb 20, 2026 | Filing Doc |
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $99.27M | $135.1M | $240.17M |
| Total non-current assets * | $17.96M | $28.87M | $273.43M |
| Total assets | $117.22M | $163.98M | $513.59M |
| Total current liabilities | $53.27M | $63.3M | $99.24M |
| Total non-current liabilities * | $92.6M | $97.39M | $22.88M |
| Total equity | -$28.64M | $3.29M | $391.48M |
ownership over time
filing count by report period · click a bar for that quarter’s holders